Cargando…

The Essentials of Multiomics

Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marshall, John L, Peshkin, Beth N, Yoshino, Takayuki, Vowinckel, Jakob, Danielsen, Håvard E, Melino, Gerry, Tsamardinos, Ioannis, Haudenschild, Christian, Kerr, David J, Sampaio, Carlos, Rha, Sun Young, FitzGerald, Kevin T, Holland, Eric C, Gallagher, David, Garcia-Foncillas, Jesus, Juhl, Hartmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Cancer Diagnostics and Molecular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982374/ https://www.ncbi.nlm.nih.gov/pubmed/35380712 http://dx.doi.org/10.1093/oncolo/oyab048

Ejemplares similares

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator
por: Stenzinger, Albrecht, et al.
Publicado: (2023)

Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016)

Two Cases of Breast Cancer With Gastric Metastasis
por: Ito, Akane, et al.
Publicado: (2023)

Tumour heterogeneity poses a significant challenge to cancer biomarker research
por: Cyll, Karolina, et al.
Publicado: (2017)

Outbreak of pasteurellosis in captive Bolivian squirrel monkeys (Saimiri boliviensis)
por: YOSHINO, Mizuki, et al.
Publicado: (2017)

Citrobacter koseri related abortion and fetal septicemia in cattle
por: HASHIGUCHI, Miteki, et al.
Publicado: (2023)

The Add-On Effect of Fluorouracil, Epirubicin, and Cyclophosphamide Regimens for Neoadjuvant Chemotherapy in Human Epidermal Receptor 2 (HER2)-Positive Breast Cancer: A Single-Center Retrospective Study
por: Yoshino, Ryusei, et al.
Publicado: (2023)

Radiation-Associated Breast Angiosarcoma
por: Yoshino, Ryusei, et al.
Publicado: (2023)

Surgical Treatment of Secondary Pneumothorax-Complicated Interstitial Lung Disease
por: Yoshino, Ryusei, et al.
Publicado: (2023)

Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms
por: Franses, Joseph W., et al.
Publicado: (2017)

An Atypical Presentation of Soft Tissue Metastasis in a Patient With Lung Cancer
por: Tvedten, Erika, et al.
Publicado: (2021)

Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings
por: Sturgill, Emma G, et al.
Publicado: (2022)

Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
por: Murugesan, Karthikeyan, et al.
Publicado: (2022)

Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
por: Al Zoughbi, Wael, et al.
Publicado: (2021)

Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer
por: Cristóbal, I, et al.
Publicado: (2014)

Enhancing Next‐Generation Sequencing‐Guided Cancer Care Through Cognitive Computing
por: Patel, Nirali M., et al.
Publicado: (2017)

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers
por: Hirshfield, Kim M., et al.
Publicado: (2016)

Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disorders
por: Molina-Ramírez, Leslie Patricia, et al.
Publicado: (2022)

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network
por: Dias-Santagata, Dora, et al.
Publicado: (2022)

Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors
por: Kearley, Karen, et al.
Publicado: (2014)

<i>CYLD</i> GeneticTesting for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas
por: Dubois, Anna, et al.
Publicado: (2015)

Genetic testing for long QT syndrome and the category of cardiac ion channelopathies
por: Modell, Stephen M., et al.
Publicado: (2012)

Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases
por: Bick, David, et al.
Publicado: (2019)

Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach
por: Kato, Shumei, et al.
Publicado: (2017)

Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer
por: Guo, Yun, et al.
Publicado: (2020)

Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
por: Le Large, Tessa Y.S., et al.
Publicado: (2020)

The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
por: Disel, Umut, et al.
Publicado: (2019)

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions
por: Jardim, Denis L., et al.
Publicado: (2020)

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors
por: Takeda, Masayuki, et al.
Publicado: (2021)

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design
por: Ross, Jeffrey S., et al.
Publicado: (2020)

One‐Step Polymerase Chain Reaction‐Free Nanowire‐Based Plasma Cell‐Free DNA Assay to Detect EML4‐ALK Fusion and to Monitor Resistance in Lung Cancer
por: Lee, Youngjoo, et al.
Publicado: (2021)

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020)

Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary
por: Fusco, Michael J, et al.
Publicado: (2022)

Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents
por: Janse van Rensburg, Helena J, et al.
Publicado: (2022)

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience
por: Pauli, Chantal, et al.
Publicado: (2021)

Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma
por: Yu, Pengfei, et al.
Publicado: (2021)

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
por: Peng, Wenying, et al.
Publicado: (2022)

Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice
por: Choucair, Khalil, et al.
Publicado: (2022)

Homologous Recombination Deficiency: Concepts, Definitions, and Assays
por: Stewart, Mark D, et al.
Publicado: (2022)

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology
por: Kang, Cyra Y, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4570odledq1f7trcmssdfjqii